גרדסיל

Ország: Izrael

Nyelv: héber

Forrás: Ministry of Health

Aktív összetevők:

PROTEIN L1 (TYPE 11) 40 MCG / 0.5 ML; PROTEIN L1 (TYPE 16) 40 MCG / 0.5 ML

Beszerezhető a:

MERCK SHARP & DOHME ISRAEL LTD

ATC-kód:

J07X

Gyógyszerészeti forma:

SUSPENSION FOR INJECTION

Az alkalmazás módja:

I.M

Gyártó:

MERCK SHARP & DOHME CORP., USA

Terápiás javallatok:

GARDASIL is indicated in females aged 9 through 45 years* for the prevention of cervical, vulvar, vaginal cancer, precancerous or dysplastic lesions, genital warts, and infection caused by Human Papillomavirus (HPV) Types 6, 11, 16, and 18 (which are included in the vaccine). GARDASIL is indicated in males 9 through 26 years* of age for the prevention of anal cancer, precancerous or dysplastic lesions, external genital lesions and infection caused by HPV types 6, 11, 16, and 18 (which are included in the vaccine). *Immunogenicity studies have been conducted to link efficacy in females and males aged 16 to 26 years to the younger populations.

Engedély dátuma:

2012-05-01